Hikal Secures Swissmedic GMP Certification for Bengaluru API Facility
Hikal Ltd 路 Press Release 路 30 Oct 2026, 1:37 pm
Hikal Secures Swissmedic GMP Certification for Bengaluru API Facility Hikal announced on 30th Oct'26 that Swissmedic has granted a Certificate of GMP Compliance to its Bengaluru API facility, confirming compliance with EU-Switzerland Mutual Recognition Agreement standards. This approval follows prior successful inspections by Brazil鈥檚 ANVISA and Japan鈥檚 PMDA. The regulatory milestone strengthens the facility's compliance standing, expands commercial access to European and key regulated markets, and supports the company鈥檚 strategic objective to geographically diversify its pharmaceutical business.
Original exchange filing (PDF)
More announcements from Hikal Ltd
- Transcript of Earnings Call for the Quarter and half year ended September 30, 2026. 路 05 Nov 2026
- Audio Recording of Group Conference call for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Result presentation for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Announcement under Regulation 30 of SEBI LODR 2015- Press Release on the results of the Company for the quarter and half year ended September 30, 2026. 路 03 Nov 2026
- Pursuant to Regulation 30(5) of the SEBI LODR Regulations- List of KMP authorized to determine materiality and make disclosures. 路 03 Nov 2026
- Unaudited Financial Results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
- Hikal Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
- Unaudited Financial Results for the quarter and half year ended September 30, 2026 路 03 Nov 2026
